Searched for
CLINICAL TRIALS AI
Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
Bengaluru-based startup leans on cancer-sniffing dogs and AI for early detectionBilly, Jessie and Banu are part of a team of beagles, labradors, Dutch shepherds and other dog breeds being trained by startup Dognosis to ...
How AI is helping pharma prevent drug recalls, counter fakes and improve patient safetyArtificial intelligence is revolutionizing the pharmaceutical sector by significantly reducing the instances of drug recalls. By improving ...
Can AI shorten India's rare disease diagnosis journey? New tool aims to do just thatSanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...
With a little help from pharma friends: Psychedelics for psychiatric therapyEli Lilly's acquisition signals a return of psychedelic drugs for mental health. These compounds offer a new approach to rewiring neural co...
Bristol Myers buys Nvidia's latest AI computing system for drug researchBristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery ...
Is Your Leadership Style Too Nice?Many leaders mistake being “nice” for being effective, avoiding hard conversations and decisions in ways that ultimately undermine organiza...
US companies face rise in cyber attacksCompanies worldwide are experiencing a rise in AI-driven cyberattacks and ransomware incidents. Fairlife, a Coca-Cola-owned dairy company, ...
Leading After the FounderWhen the person who built the company steps back, emotions run high—and many organizations stumble. Here’s how to manage the transition.
Match Your AI Strategy to Your Organization’s RealityArtificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...
Global Market: European shares rebound as tech stocks recover; investors assess Middle East developmentsEuropean stock markets traded higher on Thursday, recovering from previous losses. Technology shares led the gains, driven by renewed inter...
Deeptech startup Enlife bags Rs 6 crore to develop AI blood test for Alzheimer'sThe startup aims to replace costly and invasive scans with an AI-powered diagnostic platform tailored for the Indian population. Enlife on ...
Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's LaboratoriesDr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He ...
Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...
UnitedHealth’s $3 billion AI push has bots calling doctorsThe largest US health insurer plans to invest $3 billion in AI over 2026 and 2027. UnitedHealth executives say they’re seeing a 2-to-1 retu...
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
Drugmakers turn to AI to speed trials, regulatory submissionsAI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks off these labor-intensi...
Eyestem partners with RetinAI for treatment of geographic atrophy with AI techGeographic atrophy can lead to irreversible loss of vision over time and currently affects 200 million people globally.
AI startup Unlearn raises $15 million in funding, adds OpenAI CTO Mira Murati to boardMira Murati, chief technology officer at Microsoft-backed OpenAI, is joining the startup's board.